Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.720
+0.090 (5.52%)
At close: Aug 28, 2025, 4:00 PM
1.650
-0.070 (-4.07%)
After-hours: Aug 28, 2025, 6:43 PM EDT

Adagio Medical Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
0.320.60.30.19
Revenue Growth (YoY)
-19.30%100.67%58.73%-
Cost of Revenue
2.693.321.310.88
Gross Profit
-2.37-2.72-1.01-0.69
Selling, General & Admin
17.820.0211.545.37
Research & Development
11.5212.2215.417.86
Operating Expenses
29.3232.2426.9423.23
Operating Income
-31.69-34.96-27.94-23.91
Interest Expense
-2.79-2.92-1.66-0.14
Interest & Investment Income
0.690.4200.04
Other Non Operating Income (Expenses)
9.3311.62-6.990.34
EBT Excluding Unusual Items
-24.46-25.84-36.59-23.67
Impairment of Goodwill
-30.32-30.32--
Asset Writedown
-18.88-18.88--
Pretax Income
-73.66-75.04-36.59-23.67
Net Income
-73.66-75.04-36.59-23.67
Net Income to Common
-73.66-75.04-36.59-23.67
Shares Outstanding (Basic)
14711
Shares Outstanding (Diluted)
14711
Shares Change (YoY)
1715.89%780.27%1.10%-
EPS (Basic)
-5.27-11.22-48.16-31.50
EPS (Diluted)
-5.38-11.22-48.16-31.50
Free Cash Flow
-29.3-31.11-25.99-22.9
Free Cash Flow Per Share
-2.10-4.65-34.20-30.48
Operating Margin
-9840.06%-5806.98%-9314.00%-12652.38%
Profit Margin
-22875.16%-12465.28%-12196.67%-12525.40%
Free Cash Flow Margin
-9098.76%-5167.28%-8661.67%-12118.52%
EBITDA
-30.34-33.57-27.41-23.42
D&A For EBITDA
1.341.390.530.5
EBIT
-31.69-34.96-27.94-23.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q